Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.96%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$250M
Cap. Flow %
-5.27%
Top 10 Hldgs %
49.5%
Holding
1,224
New
10
Increased
9
Reduced
12
Closed
13

Sector Composition

1 Real Estate 58.35%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RVNC
1076
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
317
AXNX
1077
DELISTED
Axonics, Inc. Common Stock
AXNX
$5K ﹤0.01%
192
NGM
1078
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$5K ﹤0.01%
376
NSTG
1079
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
202
AIMT
1080
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$5K ﹤0.01%
357
ADVM icon
1081
Adverum Biotechnologies
ADVM
$73.9M
$4K ﹤0.01%
44
AMPH icon
1082
Amphastar Pharmaceuticals
AMPH
$1.37B
$4K ﹤0.01%
265
CERS icon
1083
Cerus
CERS
$255M
$4K ﹤0.01%
871
CYTK icon
1084
Cytokinetics
CYTK
$6.34B
$4K ﹤0.01%
363
GMAB icon
1085
Genmab
GMAB
$16.9B
$4K ﹤0.01%
171
GOSS icon
1086
Gossamer Bio
GOSS
$668M
$4K ﹤0.01%
373
HCM icon
1087
HUTCHMED
HCM
$2.74B
$4K ﹤0.01%
235
INO icon
1088
Inovio Pharmaceuticals
INO
$148M
$4K ﹤0.01%
47
NTLA icon
1089
Intellia Therapeutics
NTLA
$1.29B
$4K ﹤0.01%
288
OMER icon
1090
Omeros
OMER
$284M
$4K ﹤0.01%
309
RCKT icon
1091
Rocket Pharmaceuticals
RCKT
$354M
$4K ﹤0.01%
284
RYTM icon
1092
Rhythm Pharmaceuticals
RYTM
$6.78B
$4K ﹤0.01%
248
SGMO icon
1093
Sangamo Therapeutics
SGMO
$165M
$4K ﹤0.01%
654
STOK icon
1094
Stoke Therapeutics
STOK
$1.13B
$4K ﹤0.01%
185
TVTX icon
1095
Travere Therapeutics
TVTX
$1.93B
$4K ﹤0.01%
263
QTTB icon
1096
Q32 Bio
QTTB
$20.4M
$4K ﹤0.01%
14
EGRX
1097
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4K ﹤0.01%
82
AERI
1098
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$4K ﹤0.01%
261
RDUS
1099
DELISTED
Radius Health, Inc.
RDUS
$3K ﹤0.01%
261
AKRO icon
1100
Akero Therapeutics
AKRO
$3.58B
$3K ﹤0.01%
161